Insufficient scRNA-seq data for expression of BRF2 at single-cell level.
Insufficient scRNA-seq data for expression of BRF2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 384.29 | 1808 / 1809 | 98% | 10.30 | 463 / 472 |
intestine | 100% | 303.62 | 965 / 966 | 98% | 8.16 | 514 / 527 |
breast | 100% | 361.86 | 459 / 459 | 97% | 14.37 | 1089 / 1118 |
pancreas | 98% | 186.22 | 323 / 328 | 98% | 6.61 | 175 / 178 |
stomach | 99% | 255.36 | 357 / 359 | 97% | 7.31 | 278 / 286 |
lung | 98% | 259.36 | 567 / 578 | 99% | 10.06 | 1138 / 1155 |
prostate | 100% | 268.42 | 245 / 245 | 96% | 7.42 | 484 / 502 |
brain | 97% | 228.77 | 2562 / 2642 | 99% | 9.86 | 701 / 705 |
thymus | 100% | 243.66 | 651 / 653 | 96% | 7.85 | 580 / 605 |
ovary | 100% | 364.94 | 180 / 180 | 95% | 6.68 | 410 / 430 |
uterus | 100% | 409.68 | 170 / 170 | 95% | 7.93 | 435 / 459 |
bladder | 100% | 364.86 | 21 / 21 | 94% | 8.10 | 475 / 504 |
esophagus | 100% | 269.14 | 1444 / 1445 | 94% | 5.67 | 172 / 183 |
kidney | 100% | 203.33 | 89 / 89 | 92% | 6.05 | 826 / 901 |
adrenal gland | 98% | 295.71 | 252 / 258 | 85% | 7.08 | 196 / 230 |
liver | 96% | 126.96 | 218 / 226 | 75% | 3.69 | 306 / 406 |
adipose | 100% | 352.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 811.71 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 267.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.36 | 1 / 1 |
blood vessel | 100% | 339.49 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.71 | 79 / 80 |
heart | 95% | 225.17 | 818 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.77 | 27 / 29 |
peripheral blood | 80% | 198.47 | 744 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0070897 | Biological process | transcription preinitiation complex assembly |
GO_0006359 | Biological process | regulation of transcription by RNA polymerase III |
GO_0006352 | Biological process | DNA-templated transcription initiation |
GO_0097550 | Cellular component | transcription preinitiation complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000126 | Cellular component | transcription factor TFIIIB complex |
GO_0005634 | Cellular component | nucleus |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0001006 | Molecular function | RNA polymerase III type 3 promoter sequence-specific DNA binding |
Gene name | BRF2 |
Protein name | Transcription factor IIIB 50 kDa subunit (TFIIIB50) (hTFIIIB50) (B-related factor 2) (BRF-2) (hBRFU) Transcription factor IIIB 50 kDa subunit (B-related factor 2) BRF2 RNA polymerase III transcription initiation factor subunit |
Synonyms | BRFU PRO1470 |
Description | FUNCTION: General activator of RNA polymerase III transcription. Factor exclusively required for RNA polymerase III transcription of genes with promoter elements upstream of the initiation sites . Contributes to the regulation of gene expression; functions as activator in the absence of oxidative stress . Down-regulates expression of target genes in response to oxidative stress . Overexpression protects cells against apoptosis in response to oxidative stress . . |
Accessions | E5RGF6 Q9HAW0 E5RGX1 ENST00000220659.11 [Q9HAW0-1] ENST00000522539.1 ENST00000520601.5 ENST00000521170.5 |